Enhanced Rapid Screening for Multidrug-resistant tuberculosis through combined cardiometabolic and inflammatory indices: a cross-sectional study
Shaozhan Yuan, Haiyan Shi, Yong Cui, Yan Liu, Meizhi Cai, Yifan Huang · 2024
Read Enhanced Rapid Screening for Multidrug-resistant tuberculosis through combined cardiometabolic and inflammatory indices: a cross-sectional study by Shaozhan Yuan, Haiyan Shi, Yong Cui, Yan Liu, Meizhi Cai, Yifan Huang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11611886.txt.
Description
Shaozhan Yuan, Haiyan Shi, Yong Cui, Yan Liu, Meizhi Cai, and Yifan Huang combine two blood indexes to screen for drug-resistant tuberculosis, in a 2024 study. Multidrug-resistant TB resists the standard cures and needs long, harsh treatment. Lab confirmation is slow, so a fast blood-based flag would help clinics act sooner.
Records covered 2,620 TB patients in Zibo, China, from 2018 to 2021. Resistance appeared in five percent of new cases and over twenty percent of repeat cases. A heart-metabolic index and an inflammation index each tracked with resistance, and together they discriminated far better, scoring 0.910 on the standard curve measure in new patients. Cheap indexes from routine blood work could triage who needs urgent resistance testing.
Catalog record
| CREATOR | Shaozhan Yuan, Haiyan Shi, Yong Cui, Yan Liu, Meizhi Cai, Yifan Huang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |